Evidence map›Paper›PMID 25975770›Full record

ArticleJournal of gastroenterology2016

Erratum to: NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.

Yoko Oshima, Hideaki Shimada, Satoshi Yajima, Tatsuki Nanami, Kazuyuki Matsushita, Fumio Nomura, Osamu Kainuma, Nobuhiro Takiguchi, Hiroaki Soda, Takeshi Ueda and 10 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Yoko OshimaDepartment of Surgery, School of Medicine, Toho University, Tokyo, Japan.
Hideaki ShimadaDepartment of Surgery, School of Medicine, Toho University, Tokyo, Japan. hideaki.shimada@med.toho-u.ac.jp.
Satoshi YajimaDepartment of Surgery, School of Medicine, Toho University, Tokyo, Japan.
Tatsuki NanamiDepartment of Surgery, School of Medicine, Toho University, Tokyo, Japan.
Kazuyuki MatsushitaMolecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Fumio NomuraMolecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Osamu KainumaDivision of Gastroenterological Surgery, Chiba Cancer Center, Chiba, Japan.
Nobuhiro TakiguchiDivision of Gastroenterological Surgery, Chiba Cancer Center, Chiba, Japan.
Hiroaki SodaDivision of Gastroenterological Surgery, Chiba Cancer Center, Chiba, Japan.
Takeshi UedaDivision of Urology, Chiba Cancer Center, Chiba, Japan.
Toshihiko IizasaDivision of Thoracic Disease, Chiba Cancer Center, Chiba, Japan.
Naoto YamamotoDivision of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
Hiroshi YamamotoDivision of Gastroenterological Surgery, Chiba Cancer Center, Chiba, Japan.
Matsuo NagataDivision of Gastroenterological Surgery, Chiba Cancer Center, Chiba, Japan.
Sana YokoiDivision of Clinical Genomics, Chiba Cancer Center, Chiba, Japan.
Masatoshi TagawaDivision of Pathology and Cell Therapy, Chiba Cancer Center, Chiba, Japan.
Seiko OhtsukaDepartment of Surgery, School of Medicine, Toho University, Tokyo, Japan.
Akiko KuwajimaMedical & Biological Laboratories Co., Ltd, Nagoya, Japan.
Akihiro MurakamiMedical & Biological Laboratories Co., Ltd, Nagoya, Japan.
Hironori KanekoDepartment of Surgery, School of Medicine, Toho University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25975770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.